← Eichor
Study identifier: NCT07183488 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Metabolic Effects of Short-Chain Fatty Acids in Healthy Individuals

Condition: Healhty · Other: Short-Chain Fatty Acid (SCFA) · Other: Butyrate (C4)  ·  Sponsor: University of Copenhagen

PhaseNA
Planned participants10
Who can joinAll sexes, 18 Years to 40 Years
Healthy volunteersYes

About this study

The primary objective of this study is to investigate the acute physiological and metabolic effects of ingesting the short-chain fatty acids (SCFA)s propionate (three carbon atoms long; C3:0) and butyrate (C4:0) in healthy men and women. This aim will be addressed through a block-randomized cross-over study including two visits with acute intake of propionate and butyrate, respectively. The hypothesis is that plasma ketone body levels will increase during the first three hours after intake of butyrate, but not propionate, in healthy individuals in the overnight fasted state.

This description comes directly from the study's public registry record.

Talk to the study team

Amalie S Frederiksen, PhD student  ·  +4528899561  ·  amalie.sfrederiksen@sund.ku.dk

Andreas M Fritzen, Associate Professor  ·  amfritzen@sund.ku.dk

Always discuss trial participation with your own doctor first.

Locations (1)

University of CopenhagenCopenhagen, Copenhagen N, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07183488